SCHEMBL4905006

SCHEMBL4905006

O=C(NO)c1nccc2ccn(Cc3cccc(Cl)c3F)c12

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KLKB1 P03952 1/20 0.36
HDAC6 Q9UBN7 6/20 0.36
HDAC1 Q13547 4/20 0.36
HDAC3 O15379 2/20 0.36
P2RX7 Q99572 2/20 0.36
HDAC4 P56524 1/20 0.36
PCSK9 Q8NBP7 1/20 0.36
SGMS2 Q8NHU3 1/20 0.35
CFD P00746 3/20 0.35
GRM4 Q14833 2/20 0.35
JAK2 O60674 2/20 0.35
ADRA2A P08913 1/20 0.35
ADRA2B P18089 1/20 0.35
ADRA2C P18825 1/20 0.35
HDAC2 Q92769 2/20 0.34
HDAC10 Q969S8 1/20 0.34
HDAC8 Q9BY41 1/20 0.34
HDAC9 Q9UKV0 1/20 0.34
KMO O15229 1/20 0.34
FLT1 P17948 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4907173 0.83 GABRA1 (0.39) KLKB1
SCHEMBL2943380 0.76 MAOB (0.40) HDAC6HDAC1HDAC3HDAC4HDAC2
SCHEMBL2945173 0.67 KMO (0.43) KMOFLT1KDR
SCHEMBL4905001 0.67 ECE1 (0.40) KLKB1PCSK9SGMS2CFD
SCHEMBL6086339 0.66 HTR6 (0.49) HDAC6HDAC1HDAC2HDAC10HDAC8
SCHEMBL31729705 0.65 MRGPRX4 (0.43) FLT1KDR
SCHEMBL12584284 0.65 PKM (0.40) HDAC6HDAC1HDAC3HDAC2HDAC8
SCHEMBL12584270 0.65 HSP90AA1 (0.47)
SCHEMBL1608625 0.65 FLT1 (0.43) HDAC6HDAC1HDAC3HDAC4JAK2
SCHEMBL31729726 0.65 MRGPRX4 (0.44) CFDFLT1KDR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080221154-A1 HIV-INTEGRASE INHIBITORS, PHARMACEUTICAL COMPOSITIONS, AND METHODS FOR THEIR USE PFIZER INC 2008-09-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080221154-A1 HIV-INTEGRASE INHIBITORS, PHARMACEUTICAL COMPOSITIONS, AND METHODS FOR THEIR USE TYMP, IMPDH1, POLB KLKB1 2975/4885HDAC6 570/4885HDAC1 18/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.